Bruce Leicher,

Bruce Leicher is a strategic C-suite leader with over 30 years of experience in the biopharma industry, serving both management teams and boards of directors. He has a proven track record of building emerging and development-stage companies, guiding them through product development, launch, and successful exit strategies.

Bruce brings significant expertise in legal, regulatory, public policy, and strategic transactions, and is highly valued as an advisor for his business acumen and ability to build high-performing teams that address complex regulatory, legal, and operational challenges. With extensive corporate governance experience, he serves as a trusted advisor to multiple boards, providing strategic guidance across a broad range of biopharma initiatives.